Genentech- Building 20

Genentech Building 42 is a biotechnology company based in South San Francisco, CA, specializing in the research and development of innovative therapies for various medical conditions. With a focus on cutting-edge science and technology, the company is committed to advancing healthcare through the discovery of new treatments and solutions to improve patient outcomes. Generated from their business information

Hoffmann-La Roche, also known as Roche, is prescription drug unit that provides more than 35 medications in the United States in therapeutic areas, including dermatology, oncology, transplantation, AIDS, central nervous system disorders, and cardiovascular and infectious diseases. It offers products that include Accutane, Boniva, CellCept, Copegus, Cytovene, Demadex EC-Naprosyn, Romazicon, Tamiflu, Ticlid, Valcyte, Valium, Xeloda, Xenical and Zenapax. The company operates over five research centers in New Jersey and California in the United States, as well as Switzerland, Germany and China. Hoffmann-La Roche works with a team of nearly 5,000 employees. It is a part of Roche Group, which is one of the world's leading research-oriented health care groups with core businesses in pharmaceuticals and diagnostics. Operational for more than 100 years, the parent company develops a range of products and services that address prevention, diagnosis and treatment of diseases.

KaloBios Pharmaceuticals is a private monoclonal company based in South San Francisco, CA, focused on developing human body antibody therapeutics. With over seven products successfully advancing past phase one trials, the lab at KaloBios continues to innovate and create new therapeutic solutions for a variety of medical conditions. Generated from their available business information